Below are the most recent publications written about "Arteriovenous Shunt, Surgical" by people in Profiles.
-
Fang Z, Judelson D, Simons J, Steppacher R, Arous E, Sideman M, Schanzer A, Aiello FA. Vascular Surgeons Are Not Adequately Valued by Traditional Productivity Metrics. Ann Vasc Surg. 2021 May; 73:446-453.
-
Paredes LG, Arinze NV, Farber A, Garofalo D, Cheng TW, Levin SR, Vilvendhan R, Siracuse JJ. Periprocedural Outcomes in Patients on Chronic Anticoagulation Undergoing Fistulograms. Ann Vasc Surg. 2021 Jan; 70:123-130.
-
Arinze N, Ryan T, Pillai R, Vilvendhan R, Farber A, Jones DW, Rybin D, Levin SR, Cheng TW, Siracuse JJ. Perioperative and long-term outcomes after percutaneous thrombectomy of arteriovenous dialysis access grafts. J Vasc Surg. 2020 12; 72(6):2107-2112.
-
Dicken QG, Cheng TW, Farber A, Levin SR, Jones DW, Malas MB, Tan TW, Rybin D, Siracuse JJ. Patients with human immunodeficiency virus infection do not have inferior outcomes after dialysis access creation. J Vasc Surg. 2020 12; 72(6):2113-2119.
-
Farber A, Cheng TW, Nimmich A, Jones DW, Kalish JA, Eslami MH, Hardouin S, Siracuse JJ. Femoral vein transposition is a durable hemodialysis access for patients who have exhausted upper extremity options. J Vasc Surg. 2020 03; 71(3):929-936.
-
Levin SR, Farber A, Cheng TW, Arinze N, Jones DW, Kalish JA, Rybin D, Siracuse JJ. Risk assessment of significant upper extremity arteriovenous graft infection in the Vascular Quality Initiative. J Vasc Surg. 2020 03; 71(3):913-919.
-
Pike SL, Farber A, Arinze N, Levin S, Cheng TW, Jones DW, Tan TW, Malas M, Rybin D, Siracuse JJ. Patients with lower extremity dialysis access have poor primary patency and survival. J Vasc Surg. 2019 12; 70(6):1913-1918.
-
Siracuse JJ, Cheng TW, Arinze NV, Levin SR, Jones DW, Malas MB, Kalish JA, Rybin D, Farber A. Snuffbox arteriovenous fistulas have similar outcomes and patency as wrist arteriovenous fistulas. J Vasc Surg. 2019 Aug; 70(2):554-561.
-
Landry DL, Braden GL, Yee J. Hemodialysis Catheter Device Protection: Damned if We Do; Patients Are Damned if We Don't. Adv Chronic Kidney Dis. 2019 01; 26(1):1-4.
-
Cheng TW, Farber A, Eslami MH, Kalish JA, Jones DW, Rybin D, Siracuse JJ. Removal of infected arteriovenous grafts is morbid and many patients do not receive a new access within 1?year. J Vasc Surg. 2019 Jul; 70(1):193-198.